Nature Biotechnology 24, 730 (2006)
Published online: 6 July 2006; | doi:10.1038/nbt0706-730
Merck moves into biotechJim Kling
Bellingham, Washington
In May, Merck, one of the oldest and stodgiest pharmaceutical companies, entered the biotech arena by announcing its plans to purchase two protein manufacturing firms: GlycoFi for $400 million and Abmaxis for $80 million.
|
